By SquaredTown on June 26, 2025
UNION, N.J., June 26, 2025 /PRNewswire/ -- Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into a licensing agreement with Northern Antibiotics on June 4, 2025. As...